Jorg B. Otte
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.
Journal: Cancer letters
Published: February 25, 2025
Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State.
Journal: Cancer research
Published: May 06, 2024
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 15, 2023
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma.
Journal: JCI insight
Published: August 03, 2021
MYCN Function in Neuroblastoma Development.
Journal: Frontiers in oncology
Published: October 30, 2020
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin.
Journal: Nature genetics
Published: March 30, 2020
FGF Signalling in the Self-Renewal of Colon Cancer Organoids.
Journal: Scientific reports
Published: July 23, 2019
Gene expression profiling in aggressive digital papillary adenocarcinoma sheds light on the architecture of a rare sweat gland carcinoma.
Journal: The British journal of dermatology
Published: November 16, 2018
Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature.
Journal: Stem cell research & therapy
Published: October 02, 2018
Combined ultra-low input mRNA and whole-genome sequencing of human embryonic stem cells.
Journal: BMC genomics
Published: July 07, 2015
Last Updated: 09/26/2026